83_FR_38870 83 FR 38718 - National Institute of Diabetes and Digestive and Kidney Diseases Notice of Meetings

83 FR 38718 - National Institute of Diabetes and Digestive and Kidney Diseases Notice of Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 152 (August 7, 2018)

Page Range38718-38719
FR Document2018-16790

Federal Register, Volume 83 Issue 152 (Tuesday, August 7, 2018) 
[Federal Register Volume 83, Number 152 (Tuesday, August 7, 2018)]
[Notices]
[Pages 38718-38719]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-16790]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases 
Notice of Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the National Diabetes 
and Digestive and Kidney Diseases Advisory Council.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council.
    Date: September 7, 2018.
    Open: 8:30 a.m. to 12:00 p.m.
    Agenda: To present the Director's Report and other scientific 
presentations.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Closed: 1:00 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Karl F. Malik, Ph.D., Acting Director, Division 
of Extramural Activities, National Institutes of Diabetes and 
Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 
5452, Bethesda, MD 20892, (301) 594-4757, malikk@niddk.nih.gov.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Kidney, Urologic and Hematologic Diseases 
Subcommittee.
    Date: September 7, 2018.
    Open: 1:00 p.m. to 2:45 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 7, 31 Center Drive, Bethesda, MD 20892.
    Closed: 2:45 p.m. to 3:15 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 7, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Karl F. Malik, Ph.D., Acting Director, Division 
Of Extramural Activities, National Institutes of Diabetes and 
Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 
5452, Bethesda, MD 20892, (301) 594-4757, malikk@niddk.nih.gov.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Diabetes, Endocrinology, and Metabolic 
Diseases Subcommittee.
    Date: September 7, 2018.
    Open: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Closed: 2:00 p.m. to 3:15 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Karl F. Malik, Ph.D., Acting Director, Division 
Of Extramural Activities, National Institutes of Diabetes and 
Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 
5452, Bethesda, MD 20892, (301) 594-4757, malikk@niddk.nih.gov.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Digestive Diseases and Nutrition 
Subcommittee.
    Date: September 7, 2018.
    Open: 1:00 p.m. to 2:00 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Closed: 2:15 p.m. to 3:15 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Karl F. Malik, Ph.D., Acting Director, Division 
of Extramural Activities, National Institutes of Diabetes and 
Digestive and Kidney Diseases, 6707 Democracy Blvd., Room 7329, MSC 
5452, Bethesda, MD 20892, (301) 594-4757, malikk@niddk.nih.gov.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

[[Page 38719]]

    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm., 
where an agenda and any additional information for the meeting will 
be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: August 1, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-16790 Filed 8-6-18; 8:45 am]
 BILLING CODE 4140-01-P

38718 Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices computational workflows to facilitate DEPARTMENT OF HEALTH AND Room 7, 31 Center Drive, Bethesda, MD chemical safety assessment, by HUMAN SERVICES 20892. NICEATM. Closed: 2:45 p.m. to 3:15 p.m. National Institutes of Health Agenda: To review and evaluate grant Availability of Report: The report is applications. available at http://ntp.niehs.nih.gov/ National Institute of Diabetes and Place: National Institutes of Health, iccvamreport/2017/index.html. Links to Digestive and Kidney Diseases Notice Building 31, C Wing, 6th Floor, Conference this report and all past ICCVAM annual Room 7, 31 Center Drive, Bethesda, MD of Meetings and biennial reports are available at 20892. Pursuant to section 10(d) of the Contact Person: Karl F. Malik, Ph.D., http://ntp.niehs.nih.gov/go/iccvam-bien. Acting Director, Division Of Extramural Federal Advisory Committee Act, as Background Information on ICCVAM amended, notice is hereby given of Activities, National Institutes of Diabetes and and NICEATM: ICCVAM is an Digestive and Kidney Diseases, 6707 meetings of the National Diabetes and interagency committee composed of Democracy Blvd., Room 7329, MSC 5452, Digestive and Kidney Diseases Advisory Bethesda, MD 20892, (301) 594–4757, representatives from 16 federal Council. malikk@niddk.nih.gov. regulatory and research agencies that The meetings will be open to the Name of Committee: National Diabetes and require, use, generate, or disseminate public as indicated below, with Digestive and Kidney Diseases Advisory toxicological and safety testing attendance limited to space available. Council; Diabetes, Endocrinology, and information. ICCVAM conducts Individuals who plan to attend and Metabolic Diseases Subcommittee. technical evaluations of new, revised, need special assistance, such as sign Date: September 7, 2018. and alternative safety testing methods language interpretation or other Open: 1:00 p.m. to 2:00 p.m. and integrated testing strategies with reasonable accommodations, should Agenda: To review and evaluate grant notify the Contact Person listed below applications. regulatory applicability. ICCVAM also Place: National Institutes of Health, promotes the scientific validation and in advance of the meeting. Building 31, C Wing, 6th Floor, Conference regulatory acceptance of testing The meetings will be closed to the Room 10, 31 Center Drive, Bethesda, MD methods that more accurately assess the public in accordance with the 20892. safety and hazards of chemicals and provisions set forth in sections Closed: 2:00 p.m. to 3:15 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Agenda: To review the Division’s scientific products and replace, reduce, or refine as amended. The grant applications and and planning activities. (enhance animal well-being and lessen the discussions could disclose Place: National Institutes of Health, or avoid pain and distress) animal use. Building 31, C Wing, 6th Floor, Conference confidential trade secrets or commercial The ICCVAM Authorization Act of property such as patentable material, Room 10, 31 Center Drive, Bethesda, MD 2000 (42 U.S.C. 285l–3) establishes and personal information concerning 20892. ICCVAM as a permanent interagency Contact Person: Karl F. Malik, Ph.D., individuals associated with the grant Acting Director, Division Of Extramural committee of NIEHS and provides the applications, the disclosure of which Activities, National Institutes of Diabetes and authority for ICCVAM involvement in would constitute a clearly unwarranted Digestive and Kidney Diseases, 6707 activities relevant to the development of invasion of personal privacy. Democracy Blvd., Room 7329, MSC 5452, alternative test methods. Additional Name of Committee: National Diabetes and Bethesda, MD 20892, (301) 594–4757, information about ICCVAM can be Digestive and Kidney Diseases Advisory malikk@niddk.nih.gov. found at http://ntp.niehs.nih.gov/go/ Council. Name of Committee: National Diabetes and iccvam. Date: September 7, 2018. Digestive and Kidney Diseases Advisory Open: 8:30 a.m. to 12:00 p.m. Council; Digestive Diseases and Nutrition NICEATM administers ICCVAM, Agenda: To present the Director’s Report Subcommittee. provides scientific and operational and other scientific presentations. Date: September 7, 2018. support for ICCVAM-related activities, Place: National Institutes of Health, Open: 1:00 p.m. to 2:00 p.m. and conducts and publishes analyses Building 31, C Wing, 6th Floor, Conference Agenda: To review the Division’s scientific and evaluations of data from new, Room 10, 31 Center Drive, Bethesda, MD and planning activities. 20892. Place: National Institutes of Health, revised, and alternative testing Closed: 1:00 p.m. to 4:30 p.m. Building 31, C Wing, 6th Floor, Conference approaches. NICEATM and ICCVAM Agenda: To review and evaluate grant Room 6, 31 Center Drive, Bethesda, MD work collaboratively to evaluate new applications. 20892. and improved testing approaches Place: National Institutes of Health, Closed: 2:15 p.m. to 3:15 p.m. applicable to the needs of U.S. federal Building 31, C Wing, 6th Floor, Conference Agenda: To review and evaluate grant agencies. NICEATM and ICCVAM Room 10, 31 Center Drive, Bethesda, MD applications. welcome the public nomination of new, 20892. Place: National Institutes of Health, Contact Person: Karl F. Malik, Ph.D., Building 31, C Wing, 6th Floor, Conference revised, and alternative testing Acting Director, Division of Extramural Room 6, 31 Center Drive, Bethesda, MD approaches for validation studies and Activities, National Institutes of Diabetes and 20892. technical evaluations. Additional Digestive and Kidney Diseases, 6707 Contact Person: Karl F. Malik, Ph.D., information about NICEATM can be Democracy Blvd., Room 7329, MSC 5452, Acting Director, Division of Extramural found at http://ntp.niehs.nih.gov/go/ Bethesda, MD 20892, (301) 594–4757, Activities, National Institutes of Diabetes and niceatm. malikk@niddk.nih.gov. Digestive and Kidney Diseases, 6707 Name of Committee: National Diabetes and Democracy Blvd., Room 7329, MSC 5452, Dated: July 24, 2018. Digestive and Kidney Diseases Advisory Bethesda, MD 20892, (301) 594–4757, daltland on DSKBBV9HB2PROD with NOTICES Brian R. Berridge, Council; Kidney, Urologic and Hematologic malikk@niddk.nih.gov. Associate Director, National Toxicology Diseases Subcommittee. Any interested person may file written Program. Date: September 7, 2018. comments with the committee by forwarding Open: 1:00 p.m. to 2:45 p.m. the statement to the Contact Person listed on [FR Doc. 2018–16837 Filed 8–6–18; 8:45 am] Agenda: To review the Division’s scientific this notice. The statement should include the BILLING CODE 4140–01–P and planning activities. name, address, telephone number and when Place: National Institutes of Health, applicable, the business or professional Building 31, C Wing, 6th Floor, Conference affiliation of the interested person. VerDate Sep<11>2014 16:54 Aug 06, 2018 Jkt 244001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\07AUN1.SGM 07AUN1

Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices 38719 In the interest of security, NIH has your written comments no later than The Merchant Mariner Medical instituted stringent procedures for entrance September 5, 2018. Advisory Committee Meeting is onto the NIH campus. All visitor vehicles, authorized by U.S. Code, Title 46, including taxicabs, hotel, and airport shuttles ADDRESSES: The meetings will be held at STAR Center, 2 West Dixie Highway, section 7115. The Committee advises will be inspected before being allowed on campus. Visitors will be asked to show one Dania Beach, FL 33004, https:// the Secretary of the Department of form of identification (for example, a www.star-center.com/. Homeland Security on matters related to government-issued photo ID, driver’s license, Pre-registration Information: Pre- (a) medical certification determinations or passport) and to state the purpose of their registration is not required for access to for issuance of licenses, certificates of visit. this meeting by the public. All attendees registry, and merchant mariners’ Information is also available on the documents; (b) medical standards and Institute’s/Center’s home page: will be required to provide a driver’s license or government-issued guidelines for the physical www.niddk.nih.gov/fund/divisions/DEA/ qualifications of operators of Council/coundesc.htm., where an agenda and identification card in order to gain admittance to the building. commercial vessels; (c) medical any additional information for the meeting examiner education; and (d) medical will be posted when available. For information on facilities or research. (Catalogue of Federal Domestic Assistance services for individuals with disabilities Program Nos. 93.847, Diabetes, or to request special assistance at the Agenda Endocrinology and Metabolic Research; meeting, contact the Alternate 93.848, Digestive Diseases and Nutrition Day 1 Designated Federal Officer as soon as Research; 93.849, Kidney Diseases, Urology possible using the contact information The agenda for the September 13, and Hematology Research, National Institutes 2018, meeting is as follows: of Health, HHS) provided in the FOR FURTHER INFORMATION CONTACT section of this (1) The full Committee will meet Dated: August 1, 2018. notice. briefly to discuss the Working Groups’ David D. Clary, Instructions: You are free to submit business/task statements, which are Program Analyst, Office of Federal Advisory comments at any time, including orally listed under paragraph 2 and 3 (a)–(b) Committee Policy. at the meetings, but if you want below. [FR Doc. 2018–16790 Filed 8–6–18; 8:45 am] Committee members to review your (2) General Discussion of Mariner BILLING CODE 4140–01–P comment before the meetings, please Mental Health Issues with presentations submit your comments no later than by mariner service organizations and September 5, 2018. We are particularly industry. interested in comments on the issues in (3) Working Groups will separately DEPARTMENT OF HOMELAND the ‘‘Agenda’’ section below. You must address the following task statements, SECURITY include ‘‘Department of Homeland which are available at https:// Coast Guard Security’’ and the docket number homeport.uscg.mil/missions/ports-and- USCG–2018–0495. Written comments waterways/safety-advisory-committees/ [Docket No. USCG–2018–0495] medmac. may also be submitted using the Federal (a) Task statement 16–24 Merchant Mariner Medical Advisory eRulemaking Portal at http:// Recommendations on Appropriate Diets Committee www.regulations.gov. If you encounter and Wellness for Mariners While technical difficulties with comments AGENCY: U.S. Coast Guard, Department Onboard Merchant Vessels; and submission, contact the individual (b) Task statement 17–26, Input to of Homeland Security. listed in the FOR FURTHER INFORMATION ACTION: Notice of Federal Advisory Support Regulatory Reform of Coast CONTACT section below. Comments Committee Meeting. Guard Regulations-Executive Orders received will be posted without 13771 and 13783. alteration at http://www.regulations.gov, (4) Public comment period. SUMMARY: The Merchant Mariner including any personal information (5) Reports of Working Groups. At the Medical Advisory Committee and its provided. You may review the Privacy end of the day, the Working Groups will Working Groups will meet to discuss and Security Notice for the Federal report to the full Committee on what matters relating to medical certification Docket Management System at https:// was accomplished in their meetings. determinations for issuance of licenses, www.regulations.gov/privacyNotice. The full Committee will not take action certificates of registry, and merchant mariners’ documents, medical standards Docket Search: For access to the on these reports on this date. Any and guidelines for the physical docket, to read documents or comments official action taken as a result of these qualifications of operators of related to this notice, go to http:// Working Group meetings will be taken commercial vessels, medical examiner www.regulations.gov, type USCG–2018– on day two of the meeting. education, and medical research. The 0495 in the ‘‘Search’’ box, press Enter, (6) Adjournment of meeting. meetings will be open to the public. and then click on the item you wish to view. Day 2 DATES: The agenda for the September 14, Meetings: The Merchant Mariner FOR FURTHER INFORMATION CONTACT: Mr. Davis Breyer, Alternate Designated 2018, meeting is as follows: Medical Advisory Committee and its (1) Introduction. Working Groups are scheduled to meet Federal Officer of the Merchant Mariner (2) Designated Federal Officer on Thursday, September 13, 2018, and Medical Advisory Committee, 2703 announcements. on Friday, September 14, 2018, from Martin Luther King Jr. Ave. SE, Stop (3) Remarks from U.S. Coast Guard daltland on DSKBBV9HB2PROD with NOTICES 8:00 a.m. until 5:30 p.m. each day. 7509, Washington, DC 20593–7509, Leadership. These meetings may adjourn early if the telephone 202–372–1445, fax 202–372– (4) Roll call of Committee members Committee has completed its business. 8382 or davis.j.breyer@uscg.mil. and determination of a quorum. Comments and supporting SUPPLEMENTARY INFORMATION: Notice of (5) Reports from the following documentation: To ensure your this meeting is pursuant with the Working Groups: comments are received by Committee Federal Advisory Committee Act, Title (a) Task statement 16–24, requesting members before the meetings, submit 5 United States Code Appendix. recommendations on appropriate diets VerDate Sep<11>2014 16:54 Aug 06, 2018 Jkt 244001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\07AUN1.SGM 07AUN1


Document Created: 2018-11-06 10:39:12
Document Modified: 2018-11-06 10:39:12
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesSeptember 7, 2018.
FR Citation83 FR 38718 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR